Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Cigna Corporation is a healthcare plans business based in the US. Cigna Corporation shares (CI) are listed on the NYSE and all prices are listed in US Dollars. Cigna Corporation employs 72,226 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$202.46|
|52-week range||$156.81 - $270.48|
|50-day moving average||$212.42|
|200-day moving average||$236.44|
|Wall St. target price||$263.32|
|Dividend yield||$2 (0.97%)|
|Earnings per share (TTM)||$22.87|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-1.54%|
|1 month (2021-08-24)||-4.45%|
|3 months (2021-06-24)||-13.76%|
|6 months (2021-03-24)||-15.83%|
|1 year (2020-09-24)||25.85%|
|2 years (2019-09-24)||28.21%|
|3 years (2018-09-24)||203.24|
|5 years (2016-09-23)||54.55%|
Valuing Cigna Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cigna Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cigna Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Cigna Corporation shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Cigna Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.8236. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cigna Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cigna Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10 billion.
The EBITDA is a measure of a Cigna Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$167 billion|
|Operating margin TTM||4.87%|
|Gross profit TTM||$24.4 billion|
|Return on assets TTM||3.24%|
|Return on equity TTM||17.03%|
|Market capitalisation||$69.9 billion|
TTM: trailing 12 months
There are currently 10.0 million Cigna Corporation shares held short by investors – that's known as Cigna Corporation's "short interest". This figure is 168.5% up from 3.7 million last month.
There are a few different ways that this level of interest in shorting Cigna Corporation shares can be evaluated.
Cigna Corporation's "short interest ratio" (SIR) is the quantity of Cigna Corporation shares currently shorted divided by the average quantity of Cigna Corporation shares traded daily (recently around 2.2 million). Cigna Corporation's SIR currently stands at 4.51. In other words for every 100,000 Cigna Corporation shares traded daily on the market, roughly 4510 shares are currently held short.
However Cigna Corporation's short interest can also be evaluated against the total number of Cigna Corporation shares, or, against the total number of tradable Cigna Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cigna Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Cigna Corporation shares in existence, roughly 30 shares are currently held short) or 0.0296% of the tradable shares (for every 100,000 tradable Cigna Corporation shares, roughly 30 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cigna Corporation.
Find out more about how you can short Cigna Corporation stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Cigna Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 13.57
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Cigna Corporation's overall score of 13.57 (as at 12/31/2018) is excellent – landing it in it in the 9th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Cigna Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 0.94/100
Cigna Corporation's environmental score of 0.94 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Cigna Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 9.82/100
Cigna Corporation's social score of 9.82 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Cigna Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 3.69/100
Cigna Corporation's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Cigna Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Cigna Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Cigna Corporation hasn't always managed to keep its nose clean.
|Total ESG score||13.57|
|Total ESG percentile||8.92|
|Environmental score percentile||2|
|Social score percentile||2|
|Governance score percentile||2|
|Level of controversy||3|
Dividend payout ratio: 16.77% of net profits
Recently Cigna Corporation has paid out, on average, around 16.77% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.95% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cigna Corporation shareholders could enjoy a 1.95% return on their shares, in the form of dividend payments. In Cigna Corporation's case, that would currently equate to about $2 per share.
While Cigna Corporation's payout ratio might seem low, this can signify that Cigna Corporation is investing more in its future growth.
Cigna Corporation's most recent dividend payout was on 22 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 6 September 2021 (the "ex-dividend date").
Cigna Corporation's shares were split on a 3:1 basis on 4 June 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Cigna Corporation shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Cigna Corporation shares which in turn could have impacted Cigna Corporation's share price.
Over the last 12 months, Cigna Corporation's shares have ranged in value from as little as $156.8129 up to $270.4753. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cigna Corporation's is 0.8799. This would suggest that Cigna Corporation's shares are less volatile than average (for this exchange).
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U. S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.